Sort
85,873 grants matching “alzheimers”
Optimization of a potent and cell active CK2 chemical probe for Alzheimer's disease therapy
$833,173Alison Donnelly Axtman · Univ Of North Carolina Chapel Hill · R56 · FY2024 · AG
OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINE
$833,064Jeanne Mandelblatt · Georgetown University · R01 · FY2010 · CA
Project 4: Longitudinal Brain Imaging for Alzheimer's Biomarkers across Peri to Post Menopausal Transition: Therapeutic Targets and Windows
$832,970Lisa Mosconi · University Of Arizona · P01 · FY2022 · AG
Core B - Clinical Core
$832,933Teresa Gomez-Isla · Massachusetts General Hospital · P50 · FY2017 · AG
Sigma-1 Receptor Radioligand for Translational Research in Alzheimer's Disease
$832,864Yiyun Henry Huang · Yale University · R56 · FY2022 · AG
MITOCHONDRIAL IMPAIRMENT IN ALZHEIMERS DISEASE
$832,845University Of Virginia Charlottesville · P01 · FY2000 · AG
MRI, GENETIC AND COGNITIVE PRECURSORS OF AD AND DEMENTIA
$832,834Boston University Medical Campus · R01 · FY2002 · AG
Investigating the Temperature Dependence of Age-related Tau Pathology Relevant to Early Alzheimer's Disease
$832,740Esther Marian Blessing · New York University School Of Medicine · R01 · FY2022 · AG
Effectiveness of therapeutics and health care services in reducing racial disparities in Alzheimer's disease
$832,646Julie M Zissimopoulos · University Of Southern California · R01 · FY2017 · AG
Biogenesis of Exosomes, Secretion, and Trafficking in Alzheimer's Disease
$832,623Robert A Rissman · University Of California, San Diego · R56 · FY2017 · AG
Highly evolved brain circuits in primates: molecular vulnerabilities for disease
$832,500Amy F.t. Arnsten · Yale University · DP1 · FY2014 · AG
Highly evolved brain circuits in primates: molecular vulnerabilities for disease
$832,500Amy F.t. Arnsten · Yale University · DP1 · FY2013 · AG
Highly evolved brain circuits in primates: molecular vulnerabilities for disease
$832,500Amy F.t. Arnsten · Yale University · DP1 · FY2016 · AG
Highly evolved brain circuits in primates: molecular vulnerabilities for disease
$832,500Amy F.t. Arnsten · Yale University · DP1 · FY2017 · AG
Metabolic Control Analysis
$832,499Richard L Veech · Alcohol Abuse And Alcoholism · Z01 · FY2007 · AA
Oxidative DNA Damage And Its Processing
$832,475Vilhelm A Bohr · National Institute On Aging · ZIA · FY2016 · AG
Molecular imaging of RIPK1/necroptosis as a key biomarker in Alzheimer's disease
$832,432Changning Wang · Massachusetts General Hospital · R61 · FY2021 · AG
Molecular imaging of RIPK1/necroptosis as a key biomarker in Alzheimer's disease
$832,432Changning Wang · Massachusetts General Hospital · R61 · FY2020 · AG
Molecular imaging of RIPK1/necroptosis as a key biomarker in Alzheimer's disease
$832,432Changning Wang · Massachusetts General Hospital · R61 · FY2022 · AG
Inherited Disease, Caregiving, and Social Networks
$832,379Laura M Koehly · National Human Genome Research Institute · ZIA · FY2018 · HG
Study of Aging Latinas/os for Understanding Dementia in HIV (SALUD HIV)
$832,280Monica G Rivera-Mindt · Fordham University · R56 · FY2019 · AG
Study of Aging Latinas/os for Understanding Dementia in HIV (SALUD HIV)
$832,280Monica G Rivera-Mindt · Fordham University · R01 · FY2020 · AG
Neural substrates of diffusion imaging in cognitively aging rhesus monkeys
$832,266Marek Kubicki · Brigham And Women'S Hospital · R01 · FY2020 · AG
Magnetic Resonance Spectroscopy Core Facility
$832,128Jun Shen · National Institute Of Mental Health · ZIC · FY2024 · MH
Conformational Changes in Glutamate transporters
$832,083Joseph A Mindell · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS